Inventor · disambiguated record
Inge Thoger Christensen
Also filed as: CHRISTENSEN INGE T · CHRISTENSEN INGE THOGER
9 granted patents·10 pending applications·273 citations·filing 2001–2012
90Inventor score
Files withNOVO NORDISK AS10HIGH POINT PHARMACEUTICALS LLC5DORWALD FLORENCIO ZARAGOZA2NOVO NORDISK INC1
Top patents by PatentIndex Score
19 records- 0194US6953812B2Glucagon antagonists/inverse agonistsNOVO NORDISK INC·Filed 2003·Granted Oct 11, 2005·56 cites·54 claims
- 0293US7723323B2Pharmaceutical use of fused 1,2,4-triazolesHIGH POINT PHARMACEUTICALS LLC·Filed 2008·Granted May 25, 2010·32 cites·14 claims
- 0393US7358238B2Pharmaceutical use of fused 1,2,4-triazolesNOVO NORDISK AS·Filed 2005·Granted Apr 15, 2008·36 cites·9 claims
- 0493US6762318B2Glucagon antagonistsNOVO NORDISK AS·Filed 2002·Granted Jul 13, 2004·54 cites·59 claims
- 0592US6562807B2Glucagon antagonists/inverse agonistsNOVO NORDISK AS·Filed 2001·Granted May 13, 2003·28 cites·70 claims
- 0691US6881746B2Glucagon antagonists/inverse agonistsNOVO NORDISK AS·Filed 2003·Granted Apr 19, 2005·35 cites·32 claims
- 0790US7700583B211β-hydroxysteroid dehydrogenase type 1 active compoundsHIGH POINT PHARMACEUTICALS LLC·Filed 2005·Granted Apr 20, 2010·30 cites·17 claims
- 0873US8394842B2Benzothiazoles having histamine H3 receptor activityDORWALD FLORENCIO ZARAGOZA·Filed 2007·Granted Mar 12, 2013·2 cites·13 claims
- 0966US2010120743A111Beta-Hydroxysteroid Dehydrogenase Type 1 Active CompoundsHIGH POINT PHARMACEUTICALS LLC·Filed 2009·Application pending·0 cites
- 1062US2008108598A1Pharmaceutical use of substituted amidesNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 1160US2009143592A1Glucagon Antagonists/Inverse AgonistsNOVO NORDISK AS·Filed 2007·Application pending·0 cites
- 1256US2006111366A1Pharmaceutical use of substituted amidesNOVO NORDISK AS·Filed 2005·Application pending·0 cites
- 1351US2009264414A1Amide Derivatives and Pharmaceutical Use ThereofHIGH POINT PHARMACEUTICALS LLC·Filed 2009·Application pending·0 cites
- 1450US2003212119A1Novel glucagon receptor antagonists/inverse agonistsFiled 2002·Application pending·0 cites
- 1548US8772285B2Benzothiazoles having histamine H3 receptor activityDORWALD FLORENCIO ZARAGOZA·Filed 2012·Granted Jul 8, 2014·0 cites·12 claims
- 1648US2007015757A1Novel Glucagon Antagonists/Inverse AgonistsNOVO NORDISK AS·Filed 2006·Application pending·0 cites
- 1747US2010197658A1Pharmaceutical use of fused 1,2,4-triazolesHIGH POINT PHARMACEUTICALS LLC·Filed 2010·Application pending·0 cites
- 1844US2006100235A1Pharmaceutical use of substituted 1,2,4-triazolesNOVO NORDISK AS·Filed 2005·Application pending·0 cites
- 1941US2007270408A1Pharmaceutical use of substituted pyrazolo[1,5-a]pyrimidinesNOVO NORDISK AS·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →